CorMedix IncNASDAQ:CRMD
- LAST PRICE5.1100
- TODAY'S CHANGE (%)-0.1000 (-1.9194%)
- Bid / Lots5.0100/ 1
- Ask / Lots5.2500/ 2
- Open / Previous Close5.2100 / 5.2100
- Day Range
- 52 Week Range
- Volume536,520
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRMD |
|---|---|---|
| 09:32 ET | 6526 | 5.19 |
| 09:34 ET | 635 | 5.1695 |
| 09:36 ET | 200 | 5.18 |
| 09:38 ET | 9792 | 5.2 |
| 09:39 ET | 100 | 5.2 |
| 09:41 ET | 200 | 5.19 |
| 09:43 ET | 800 | 5.2 |
| 09:48 ET | 1700 | 5.18 |
| 09:50 ET | 1416 | 5.185 |
| 09:52 ET | 3412 | 5.145 |
| 09:54 ET | 1000 | 5.1401 |
| 09:56 ET | 790 | 5.1499 |
| 09:57 ET | 700 | 5.15 |
| 09:59 ET | 100 | 5.155 |
| 10:01 ET | 154 | 5.17 |
| 10:03 ET | 100 | 5.15 |
| 10:06 ET | 1200 | 5.135 |
| 10:08 ET | 4957 | 5.12 |
| 10:10 ET | 1701 | 5.12 |
| 10:12 ET | 771 | 5.13 |
| 10:14 ET | 100 | 5.145 |
| 10:15 ET | 1000 | 5.145 |
| 10:19 ET | 100 | 5.145 |
| 10:21 ET | 700 | 5.16 |
| 10:28 ET | 2402 | 5.1623 |
| 10:30 ET | 2833 | 5.1602 |
| 10:32 ET | 300 | 5.165 |
| 10:33 ET | 259 | 5.164 |
| 10:35 ET | 500 | 5.16 |
| 10:39 ET | 300 | 5.16 |
| 10:42 ET | 500 | 5.165 |
| 10:44 ET | 350 | 5.16 |
| 10:50 ET | 1927 | 5.14 |
| 10:51 ET | 1595 | 5.14 |
| 10:53 ET | 735 | 5.13 |
| 10:55 ET | 100 | 5.13 |
| 10:57 ET | 300 | 5.12 |
| 11:00 ET | 2211 | 5.119 |
| 11:02 ET | 1794 | 5.125 |
| 11:06 ET | 1149 | 5.14 |
| 11:08 ET | 500 | 5.15 |
| 11:11 ET | 1900 | 5.1799 |
| 11:20 ET | 200 | 5.18 |
| 11:24 ET | 445 | 5.175 |
| 11:27 ET | 26714 | 5.1801 |
| 11:29 ET | 420 | 5.18 |
| 11:31 ET | 900 | 5.19 |
| 11:33 ET | 300 | 5.19 |
| 11:36 ET | 2800 | 5.1701 |
| 11:38 ET | 458 | 5.1664 |
| 11:40 ET | 18463 | 5.1701 |
| 11:42 ET | 1800 | 5.1659 |
| 11:44 ET | 3700 | 5.1689 |
| 11:45 ET | 5601 | 5.15 |
| 11:47 ET | 583 | 5.15 |
| 11:56 ET | 445 | 5.154 |
| 11:58 ET | 100 | 5.15 |
| 12:00 ET | 4220 | 5.14 |
| 12:02 ET | 5243 | 5.15 |
| 12:05 ET | 100 | 5.15 |
| 12:07 ET | 100 | 5.16 |
| 12:09 ET | 1800 | 5.155 |
| 12:12 ET | 372 | 5.15 |
| 12:14 ET | 100 | 5.15 |
| 12:16 ET | 400 | 5.16 |
| 12:18 ET | 1140 | 5.1401 |
| 12:20 ET | 2300 | 5.15 |
| 12:21 ET | 700 | 5.1401 |
| 12:23 ET | 100 | 5.15 |
| 12:30 ET | 615 | 5.15 |
| 12:34 ET | 500 | 5.155 |
| 12:41 ET | 19594 | 5.1501 |
| 12:43 ET | 10476 | 5.14 |
| 12:45 ET | 1921 | 5.12 |
| 12:48 ET | 100 | 5.11 |
| 12:50 ET | 100 | 5.105 |
| 12:54 ET | 1200 | 5.11 |
| 12:56 ET | 3549 | 5.075 |
| 12:57 ET | 700 | 5.066 |
| 12:59 ET | 500 | 5.075 |
| 01:01 ET | 1126 | 5.06 |
| 01:03 ET | 500 | 5.06 |
| 01:08 ET | 100 | 5.065 |
| 01:10 ET | 1400 | 5.075 |
| 01:12 ET | 1451 | 5.0779 |
| 01:14 ET | 1474 | 5.0999 |
| 01:19 ET | 996 | 5.11 |
| 01:21 ET | 8122 | 5.12 |
| 01:24 ET | 150 | 5.12 |
| 01:26 ET | 395 | 5.12 |
| 01:32 ET | 590 | 5.12 |
| 01:33 ET | 700 | 5.1101 |
| 01:35 ET | 688 | 5.11 |
| 01:39 ET | 13811 | 5.08 |
| 01:42 ET | 114 | 5.08 |
| 01:44 ET | 1952 | 5.09 |
| 01:46 ET | 2200 | 5.09 |
| 01:50 ET | 24568 | 5.105 |
| 01:51 ET | 18663 | 5.075 |
| 01:53 ET | 12654 | 5.09 |
| 01:55 ET | 9845 | 5.07 |
| 01:57 ET | 10503 | 5.09 |
| 02:00 ET | 1628 | 5.0899 |
| 02:02 ET | 2152 | 5.09 |
| 02:04 ET | 1690 | 5.08 |
| 02:06 ET | 561 | 5.0763 |
| 02:08 ET | 32358 | 5.0747 |
| 02:09 ET | 22099 | 5.0739 |
| 02:11 ET | 1700 | 5.0799 |
| 02:13 ET | 100 | 5.075 |
| 02:15 ET | 4200 | 5.055 |
| 02:18 ET | 2541 | 5.06 |
| 02:20 ET | 1338 | 5.06 |
| 02:22 ET | 2652 | 5.045 |
| 02:24 ET | 100 | 5.045 |
| 02:26 ET | 7612 | 5.03 |
| 02:27 ET | 800 | 5.0484 |
| 02:29 ET | 1000 | 5.055 |
| 02:31 ET | 5290 | 5.065 |
| 02:33 ET | 2100 | 5.065 |
| 02:36 ET | 500 | 5.07 |
| 02:38 ET | 1800 | 5.0788 |
| 02:40 ET | 7055 | 5.09 |
| 02:42 ET | 200 | 5.1 |
| 02:47 ET | 712 | 5.094 |
| 02:49 ET | 2128 | 5.075 |
| 02:56 ET | 100 | 5.075 |
| 03:00 ET | 2123 | 5.07 |
| 03:02 ET | 700 | 5.07 |
| 03:03 ET | 200 | 5.0755 |
| 03:05 ET | 300 | 5.08 |
| 03:07 ET | 1120 | 5.09 |
| 03:09 ET | 2456 | 5.095 |
| 03:12 ET | 100 | 5.1 |
| 03:14 ET | 216 | 5.095 |
| 03:16 ET | 200 | 5.094 |
| 03:18 ET | 1800 | 5.095 |
| 03:20 ET | 2182 | 5.09 |
| 03:21 ET | 100 | 5.08 |
| 03:23 ET | 946 | 5.0819 |
| 03:25 ET | 194 | 5.085 |
| 03:30 ET | 908 | 5.085 |
| 03:34 ET | 300 | 5.09 |
| 03:36 ET | 235 | 5.095 |
| 03:39 ET | 100 | 5.095 |
| 03:41 ET | 100 | 5.095 |
| 03:43 ET | 1288 | 5.09 |
| 03:45 ET | 524 | 5.095 |
| 03:48 ET | 300 | 5.095 |
| 03:50 ET | 469 | 5.09 |
| 03:52 ET | 4335 | 5.09 |
| 03:54 ET | 500 | 5.09 |
| 03:56 ET | 9437 | 5.115 |
| 03:57 ET | 4332 | 5.1 |
| 03:59 ET | 4554 | 5.11 |
May 13, 2024
DJ CorMedix Price Target Maintained With a $10.00/Share by Needham, from 5:42AM ET on Monday May 13, 2024 by Dow Jones
5:42AM ET on Monday May 13, 2024 by Dow Jones
May 10, 2024
CorMedix Inc. to Participate in Two Upcoming Investor Conferences, from 8:30AM ET on Friday May 10, 2024 by Dow Jones
8:30AM ET on Friday May 10, 2024 by Dow Jones
May 9, 2024
CorMedix Inc. Reports First Quarter 2024 Financial Results and Provides Business Update, from 7:30AM ET on Thursday May 09, 2024 by Dow Jones
7:30AM ET on Thursday May 09, 2024 by Dow Jones*DJ CorMedix 1Q Loss/Shr 25c >CRMD, from 7:30AM ET on Thursday May 09, 2024 by Dow Jones
7:30AM ET on Thursday May 09, 2024 by Dow Jones
May 6, 2024
CorMedix Inc. To Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 9, 2024, from 8:30AM ET on Monday May 06, 2024 by Dow Jones
8:30AM ET on Monday May 06, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
CorMedix Inc | 286.5M | -5.5x | --- |
Cipla Ltd | 14.4B | 0.0x | --- |
Zevra Therapeutics Inc | 193.8M | -3.3x | --- |
Dbv Technologies SA | 133.4M | -1.5x | --- |
Assembly Biosciences Inc | 83.4M | -1.3x | --- |
Incannex Healthcare Inc | 42.7M | 0.0x | --- |
Company Information
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. DefenCath is a formulation of taurolidine 13.5 mg/mL, and heparin 1000 USP Units/mL indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). In addition to DefenCath, the Company has sponsored a pre-clinical research collaboration for the use of taurolidine as a possible treatment for rare pediatric tumors.
Contact Information
- Headquarters
- 300 Connell Drive, Suite 4200BERKELEY HEIGHTS, NJ, United States 07922
- Phone
- 908-517-9500
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Myron Kaplan
- Director
- Joseph Todisco
- Chief Financial Officer, Executive Vice President
- Matthew David
- Executive Vice President, Head of Clinical and Medical Affairs
- Elizabeth Massonhurlburt
- Executive Vice President, Chief Commercial Officer
- Erin Mistry
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $286.5M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 55.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.72 |
EPS | $-0.93 |
Book Value | $1.28 |
P/E Ratio | -5.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
